Skip to main content
رجوع
Watch Compare

Nu-Med Plus, Inc.

جودة البيانات: 83%
NUMD
OTC Manufacturing Measuring & Analyzing Instruments
KWD 0.01
▲ KWD 0.00 (9.24%)
القيمة السوقية: 1.09 M
السعر
KWD 0.01
القيمة السوقية
1.09 M
نطاق اليوم
KWD 0.01 — KWD 0.01
نطاق 52 أسبوعًا
KWD 0.01 — KWD 0.10
حجم التداول
14,200
فتح KWD 0.01
متوسط 50 يوم / 200 يوم
KWD 0.01
6.47% below
متوسط 50 يوم / 200 يوم
KWD 0.03
52.73% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -4,433.0

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.03
Interest Coverage-12.63

التقييم

PE (TTM)
-15.89
أقل من متوسط القطاع (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -15.9 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -68,345.0
ROE N/A ROA -862.02%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4,433.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.03
Interest Coverage -12.63 Asset Turnover N/A
Working Capital -204,541 Tangible Book Value -204,541
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -15.89 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.41%
Market Cap 1.09 M Enterprise Value 1.09 M
Per Share
EPS (Diluted TTM) 0.00 Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 6.49%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — 0.0
Net Income -68,345.0 -125,526.0 -130,167.0 -830,061.0 -2.01 M
EPS (Diluted) 0.00 0.00 0.00 -0.01 -0.04
Gross Profit — — — — —
Operating Income -63,331.0 -120,526.0 -182,167.0 -839,445.0 -1.99 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — 2,267.0 2,267.0 9,365.0 11,794.0
Interest Expense 5,014.0 -5,000.0 1,000.0 14,322.0 14,322.0
Income Tax — — — — 0.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 9,373.0 13,456.0 79,545.0 22,163.0 557,135.0
Total Liabilities 224,469.0 160,207.0 142,570.0 154,521.0 89,432.0
Shareholders' Equity -215,096.0 -146,751.0 -63,025.0 -132,358.0 467,703.0
Total Debt — — — — —
Cash & Equivalents 2,373.0 — — 188,506.0 188,506.0
Current Assets 9,373.0 13,456.0 79,545.0 11,675.0 537,523.0
Current Liabilities 224,469.0 160,207.0 142,570.0 154,521.0 80,048.0